Scientists at The University of Texas MD Anderson Cancer Center have identified a self-perpetuating “loop” of molecular activity that fuels pancreatic cancer by linking two signature characteristics of the disease – Kras, a gene that serves as a molecular on-off switch, but gets stuck on the “on” position when mutated, and NF-κB, a protein complex that controls activation of genes. In addition …
See original here:
Genetic Mutation That Triggers Pancreatic Cancer Identified
Researchers at the Columbia University College of Dental Medicine have identified a genetic variation that raises the risk of developing serious necrotic jaw bone lesions in patients who take bisphosphonates, a common class of osteoclastic inhibitors.
Read the original here:
New discovery paves way for genetic screening test
For years it was thought that a difficult birth and other perinatal factors were the leading causes of cerebral palsy (CP), a group of disorders that can involve brain and nervous system functions such as movement, learning, hearing, seeing and thinking. Now, researchers suggest that the majority of cerebral palsy causes may in fact be caused by genetic abnormalities.
Read this article:
Genetic abnormalities may cause cerebral palsy, study suggests
Researchers at the Columbia University College of Dental Medicine have identified a genetic variation that raises the risk of developing serious necrotic jaw bone lesions in patients who take bisphosphonates, a common class of osteoclastic inhibitors.
Read the original:
Study Pinpoints Genetic Variation that Raises Risk of Serious Complication Linked to Osteoporosis Drugs
Researchers have identified a genetic variation that raises the risk of developing serious necrotic jaw bone lesions in patients who take bisphosphonates, a common class of osteoclastic inhibitors.
See the original post:
Genetic variation that raises risk of serious complication linked to osteoporosis drugs identified
( Columbia University Medical Center ) Researchers at the Columbia University College of Dental Medicine have identified a genetic variation that raises the risk of developing serious necrotic jaw bone lesions in patients who take bisphosphonates, a common class of osteoclastic inhibitors. The discovery paves the way for a genetic screening test to determine who can safely take these drugs.
Visit link:
Study pinpoints genetic variation that raises a risk linked to bisphosphonates
24-01-2012 09:59 CBS Early Morning Show discusses the use of adult adipose (from fat) stem cells to regrow breast tissue for use for both cosmetic reasons and reconstructive reasons as in the case of a mastectomy.
Here is the original post:
Stem Cells Used To Regrow Breasts – Video
Reporting in The Lancet, researchers write that a preliminary study shows embryonic stem cell therapy in two patients with macular degeneration was safe. Results suggest the patients' vision improved slightly. Dr. Robert Lanza, Chief Scientific Officer of Advanced Cell Technology and co-author of the study, discusses the trial.
The rest is here:
Stem Cell Eye Therapy Shows Promise
POWAY, CA–(Marketwire -01/27/12)- Vet-Stem, Inc. today
announced that over 8,000 animals have now been treated with
Vet-Stem cell
therapy.
Vet-Stem
began providing
"lw_1327690697_1">stem cells to veterinarians in 2004
and has now provided stem cells for the treatment of over
8,000 animals. Vet-Stem was the first company to introduce
rapid turnaround
"lw_1327690697_2">stem cell services in the US. After
providing stem cells for thousands of horses, Vet-Stem
pioneered stem
cell therapy in dogs and cats and is now the world
leader in Regenerative Veterinary Medicine™. The rapid
adoption of stem cell therapy by equine veterinarians and
horse owners provided a springboard for use in small animal
veterinary medicine.
Greater than 75% of horses treated with Vet-Stem cell therapy
for tendon and ligament injuries are able to return to their
previous level of performance. Dog owners report that greater
than 80% of dogs treated with Vet-Stem cell therapy have an
improved quality of life.
“We are proud that so many dog, horse, and cat owners as well
as veterinarians have placed their trust in Vet-Stem cell
therapy. We feel a great sense of accomplishment knowing that
there are now over 8,000 horse and pet owners who have
experienced the benefit of stem cell technology. This
practical and beneficial application of technology puts stem
cell therapy into the present day instead of a future
theoretical concept,” said Bob Harman, DVM, MPVM, Founder and
CEO of Vet-Stem.
Vet-Stem is now working with small animal veterinarians to
develop other life-saving uses for stem cell therapy for
injuries and diseases that currently have few treatment
options.
More information about Vet-Stem can be found at
"http%3A//ctt.marketwire.com/%3Frelease=845502%26id=1203007%26type=1%26url=http%253a%252f%252fwww.vet-stem.com%252f"
style="color: inherit; text-decoration: none;" name=
"readabilityLink-1" id=
"readabilityLink-1">www.Vet-Stem.com
"#readabilityFootnoteLink-1" class=
"readability-DoNotFootnote" style=
"color: inherit;">[1]
About Vet-Stem, Inc.:
Vet-Stem, Inc. was formed in
2002 to bring regenerative medicine to the veterinary
profession. This privately held company delivers stem cell
and related services and products to veterinarians to treat
diseases in dogs, cats and horses. These technologies utilize
the natural healing properties inherent in all animals to
reduce pain and improve the quality of life of our animal
companions. Published studies have confirmed that
adipose-derived stem cells can dramatically improve the
healing of injuries and diseases that have had very few
treatment options in the past.
Vet-Stem holds the exclusive worldwide veterinary rights to
the Artecel (University of Pittsburgh) and University of
California adipose stem cell patent portfolio of over 55
issued patents.
Continue reading here:
Vet-Stem Announces Milestone of 8,000 Animals Treated With Vet-Stem Cell Therapy
Arthur Chovnick, a professor at the University of Connecticut, was a pioneer in the field of genetics whose influence was felt across the field of molecular genetics and biology.
The rest is here:
The Extraordinary Life Of A Genetics Pioneer At UConn
Irish researcher and biochemistry professor Martin Tangney has found a new and highly potential use for one of Ireland’s favorite products – whiskey. Tangney has discovered that biofuel can be created from the by-products of whiskey.
Here is the original post:
Irish researcher has discovered that whiskey could be used as gasoline
MOUNTAINSIDE, NJ– – PROTEONOMIX, INC. , a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced today that it will be presenting at …
18-01-2012 03:45 Tonight on the Tuesday, January 17, 2012 edition of the Infowars Nightly News: • Alex interviews Infowars contributing writer and vaccine researcher Curt Linderman Sr.
03-08-2011 12:48 (01/12/11) Lecture by Kevin Ahern of Oregon State University discussing Biochemistry Basics in BB 451. See the full course at oregonstate.edu This course can be taken for credit (wherever you live) via OSU’s ecampus.
Go here to read the rest:
Bite-Sized Biochemistry #31 – Membrane Transport II – Video
See what's happening in and around Halifax and Plympton.
Link:
BRIEFLY: Jan. 27
The success Mesa Red Mountain's team isn't the result of just one circumstance.
View post:
Team chemistry, resolve key girls basketball team's season
The parasite that causes malaria is a genetic outlier, which has prevented scientists from discovering the functions of most of its genes. Researchers at National Jewish Health and Yale University School of Medicine have devised a technique to overcome the genetic oddity of Plasmodium falciparum, the major cause of human malaria.
View original post here:
New technique to overcome genetic oddity of P. falciparum
Celgene Corporation and Avila Therapeutics, Inc., a privately held biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, today announced a definitive merger agreement under which Celgene Corporation will acquire Avila Therapeutics, Inc.
Here is the original post:
Celgene signs definitive merger agreement to acquire Avila
Some heart bypass patients are receiving cardiac stem cell transplants to try to repair damage.
Scientists believe skin stem cells could hold the key to the treatment and cure of more than 70 major diseases and conditions.
View original post here:
Medicine's next big thing could just be skin deep
Ablitech's lead product rounds up pancreatic and bladder cancer cells in laboratory tests and prevents further growth.
See the rest here:
Latest UM BioPark Tenant Seeks Partners for Testing of Cancer-Fighting Innovation
Officials at the Texas Heart Institute at St.
Excerpt from:
World-Renowned Cell-Therapy Researcher, Doris Taylor, PhD, Joins Texas Heart Institute at St. Luke’s Episcopal Hospital
1. A good crowd makes a show better, and an apathetic crowd can take away from a good show.
See the original post:
IN LAIMAN'S TERMS: 30 Thoughts About… RAW 1-23-12